Methylation profiling of plasma cell-free DNA in pediatric brain tumor patients
- 26 August 2024
- journal article
- letter
- Published by Springer Nature in Acta Neuropathologica
- Vol. 148 (1) , 1-3
Abstract
No abstract availableFunding Information
- Charlie Teo Foundation Grant (SP0075589, SP0075589, SP0075589, SP0075589, SP0075589, SP0075589, SP0075589, SP0075589)
This publication has 11 references indexed in Scilit:
- Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumorsJournal of Neuro-Oncology, 2024
- Liquid Biopsy in GlioblastomaCancers, 2022
- Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urineNeuro-Oncology, 2022
- Childhood Malignant Brain Tumors: Balancing the Bench and BedsideCancers, 2021
- Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomesNature Medicine, 2020
- Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNANature Protocols, 2019
- Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and diseaseNature Communications, 2018
- International incidence of childhood cancer, 2001–10: a population-based registry studyThe Lancet Oncology, 2017
- Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancerOncotarget, 2016
- Pediatric neuro‐oncology: Current status and future directionsAsia-Pacific Journal of Clinical Oncology, 2012